SDC2 and Alzheimer disease: Altered HSPG expression is associated with several pathological conditions, including Alzheimer’s disease (AD), wherein the increased expression of HSPGs, including the neuronal SDC (i.e., SDC3), correlates with neuronal vulnerability to disease pathology [30,31].